Important notification
04.08.2020 To the attention of interested persons EMA press release on the Global regulatory workshop on COVID-19 therapeutics #2: agreement […]
Press release
09.07.2020 To the attention of interested persons EMA press release on the finalization of the opinion on the presence of […]
Important notification
01.07.2020 To the attention of interested persons EMA press release: International regulators provide guiding principles for COVID-19 clinical trials descarca […]
Important notification
18.06.2020 To the attention of interested persons We hereby inform you that starting with 18.06.2020, the submission of applications and […]
Important notification
16.06.2020 To the attention of interested persons The NAMMD would like to inform you about the 7th Romanian Pharmacovigilance Workshop […]
Important notification
03.06.2020 To the attention of interested persons List of references of observational studies of chloroquine and hydroxychloroquine in COVID-19 patients […]
Important notification
09.04.2020 To the attention of interested persons In addition to the NAMMDR important notification published on 18.03.2020 on submission of […]
Important notification
09.04.2020 To the attention of companies conducting clinical trials Following the issuance of Order 74553/07.04.2020 on amendment and supplementation of […]
Important notification
26.03.2020 To the attention of marketing authorisation holders Information on nitrosamine impurities for marketing authorisation holders download document …
Important notification
25.03.2020 To the attention of Contract Research Organizations Please be advised on the measures established under Order 74527 / 23.03.2020 […]